Identification of a chemical as a human carcinogen usually comes from epidemiological studies, which are frequently initiated and/or confirmed by experiments with laboratory animals. For some time now, we have relied heavily upon the rodent bioassay to assess the potential hazards of chemicals in humans. This assay, although of great value, is expensive, requires 3-4 years On the whole, the human expert approach performed best, and it would appear that the more extensive and varied the information base used, the more accurate the predictive process. Approaches attempting to predict carcinogenesis primarily from chemical structure, while ignoring a cross-section of biological information, did not perform as well. A possible exception to this generalization was the method that exclusively used experimentally determined electrophilicity (ke) as a predictor. It did surprisingly well, perhaps because electrophilicity itself may be a measure of metabolic reactivity. It was suggested that some of the predictive systems would perform better if the results generated by the computer were to be evaluated by a human expert.
Several speakers analyzed the types of problems encountered with the NTP bioassay. One However, progress has been made over the past 5 years, and there is every reason to believe that the development of this scientific discipline will continue. It is hoped that the predictive process will improve the methods for selecting test chemicals, lead to a reduction in the use of laboratory animals, continue to protect the public health, and at the same time encourage new approaches to our understanding of the mechanisms of carcinogenesis.
